文献速递神经肿瘤

IV型胶原衍生血管生成抑制剂:应用液相色谱-串联质谱法发现canstatin在脑侵袭性脑膜瘤中低表达

Type IV collagen-derived angiogenesis inhibitor: canstatin low expressing in brain-invasive meningiomas using liquid chromatography-mass spectrometry (LC-MS/MS).
PubMed 文献 · J Neurooncol · 2023-02-22

研究采用液相色谱-串联质谱定量比较非侵袭性脑膜瘤(n=21)与脑侵袭性脑膜瘤(n=21)的蛋白丰度,共鉴定6498种独特蛋白,非侵袭组canstatin表达为脑侵袭组的2.1倍,免疫组化显示非侵袭组肿瘤实质canstatin染色更强(p=0.0132)。作者认为该发现为理解脑膜瘤脑侵袭机制及建立分子病理诊断、寻找治疗靶点提供了基础。

要点

  • 非侵袭性脑膜瘤canstatin表达为脑侵袭组的2.1倍。
  • 免疫组化示非侵袭组肿瘤实质canstatin染色强于脑侵袭组(p=0.0132)。
  • 作者认为canstatin低表达可能有助于分子病理诊断与靶向治疗探索。

核心结论

  • 本研究显示canstatin在脑侵袭性脑膜瘤中低表达,作者认为该发现为理解脑膜瘤脑侵袭机制提供了基础,并可能有助于建立分子病理诊断及为个性化治疗确定新治疗靶点。

研究设计与样本

  • 采用液相色谱-串联质谱定量比较非侵袭性脑膜瘤(n=21)与脑侵袭性脑膜瘤(n=21)的蛋白丰度,覆盖世界卫生组织I级和III级。
  • 分析蛋白质组差异后记录14种上調或下调最明显的蛋白,并对两组行胶质纤维酸性蛋白及最可能与脑侵袭相关蛋白的免疫组化染色。

主要发现

  • 在非侵袭性与脑侵袭性脑膜瘤中共鉴定出6498种独特蛋白。
  • 非侵袭组canstatin表达为脑侵袭组的2.1倍。
  • 免疫组化显示两组均表达canstatin,非侵袭组肿瘤实质canstatin染色更强(p=0.0132),脑侵袭组呈中等强度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Brain invasion in meningiomas is considered an indicator of more aggressive behavior and worse prognosis. But the precise definition and the prognostic role of brain invasion remains unsolved duo to lacking a standardized workflow of surgical sampling and the histopathological detection. Searching for molecular biomarker expression correlating with brain invasion, could contribute to establish a molecular pathological diagnosis without problems of subjective interobserver variation and deeply understand the mechanism of brain invasion and develop innovative therapeutic strategies. METHODS: We utilized liquid chromatography tandem mass spectrometry to quantify protein abundances between non-invasive meningiomas (n = 21) and brain-invasive meningiomas (n = 21) spanning World Health Organization grades I and III. After proteomic discrepancies were analyzed, the 14 most up-regulated or down-regulated proteins were recorded. Immunohistochemical staining for glial fibrillary acidic protein and most likely brain invasion-related proteins was performed in both groups. RESULTS: A total of 6498 unique proteins were identified in non-invasive and brain-invasive meningiomas. Canstatin expression in the non-invasive group was 2.1-fold that of the brain-invasive group. The immunohistochemical staining showed canstatin expressed in both groups, and the non-invasive group showed stronger staining for canstatin in the tumor mass (p = 0.0132) than the brain-invasive group, which showed moderate intensity. CONCLUSION: This study demonstrated the low expression of canstatin in meningiomas with brain invasion, a finding that provide a basis for understanding the mechanism of brain invasion of meningiomas and may contribute to establish molecular pathological diagnosis and identify novel therapeutic targets for personalized care.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Pei J, Li P, Gao YH, et al. Type IV collagen-derived angiogenesis inhibitor: canstatin low expressing in brain-invasive meningiomas using liquid chromatography-mass spectrometry (LC-MS/MS). J Neurooncol. 2023. PMID: 36811765. doi:10.1007/s11060-023-04256-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。